Selected research
Industry Growth & Trends
Global Loxoprofen API (Sodium Salt) Industry Growth and Trends Forecast to 2032
Market perspective
The global Loxoprofen API (Sodium Salt) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Loxoprofen API (Sodium Salt) include Anlon Healthcare, Daiichi Sankyo, Metrochem, Shinpoong Pharm, Dongyue Pharma, Hunan Jiudian Hongyang, Luoxin Pharmaceutical, Apeloa Pharmaceutical and Zhejiang Starry Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Loxoprofen API (Sodium Salt) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Loxoprofen API (Sodium Salt) market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Loxoprofen API (Sodium Salt) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Loxoprofen API (Sodium Salt).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Loxoprofen API (Sodium Salt) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Loxoprofen API (Sodium Salt) Market by Company
Anlon Healthcare
Daiichi Sankyo
Metrochem
Shinpoong Pharm
Dongyue Pharma
Hunan Jiudian Hongyang
Luoxin Pharmaceutical
Apeloa Pharmaceutical
Zhejiang Starry Pharmaceutical
Loxoprofen API (Sodium Salt) Segment by Type
Purity ≥99%
Purity<99%
Loxoprofen API (Sodium Salt) Segment by Application
Oral Dosage
External Preparation
Loxoprofen API (Sodium Salt) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loxoprofen API (Sodium Salt) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loxoprofen API (Sodium Salt) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loxoprofen API (Sodium Salt).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loxoprofen API (Sodium Salt) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Loxoprofen API (Sodium Salt) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥99%
- Purity<99%
Applications
- Oral Dosage
- External Preparation
Companies covered
- Anlon Healthcare
- Daiichi Sankyo
- Metrochem
- Shinpoong Pharm
- Dongyue Pharma
- Hunan Jiudian Hongyang
- Luoxin Pharmaceutical
- Apeloa Pharmaceutical
- Zhejiang Starry Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Loxoprofen API (Sodium Salt) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Loxoprofen API (Sodium Salt) Sales Estimates and Forecasts (2021-2032)
- 1.3 Loxoprofen API (Sodium Salt) Market by Type
- 1.3.1 Purity ≥99%
- 1.3.2 Purity<99%
- 1.4 Global Loxoprofen API (Sodium Salt) Market Size by Type
- 1.4.1 Global Loxoprofen API (Sodium Salt) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Loxoprofen API (Sodium Salt) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Loxoprofen API (Sodium Salt) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Loxoprofen API (Sodium Salt) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Loxoprofen API (Sodium Salt) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Loxoprofen API (Sodium Salt) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Loxoprofen API (Sodium Salt) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Loxoprofen API (Sodium Salt) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Loxoprofen API (Sodium Salt) Industry Trends
- 2.2 Loxoprofen API (Sodium Salt) Industry Drivers
- 2.3 Loxoprofen API (Sodium Salt) Industry Opportunities and Challenges
- 2.4 Loxoprofen API (Sodium Salt) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Loxoprofen API (Sodium Salt) Revenue (2021-2026)
- 3.2 Global Top Players by Loxoprofen API (Sodium Salt) Sales (2021-2026)
- 3.3 Global Top Players by Loxoprofen API (Sodium Salt) Price (2021-2026)
- 3.4 Global Loxoprofen API (Sodium Salt) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Loxoprofen API (Sodium Salt) Major Company Production Sites & Headquarters
- 3.6 Global Loxoprofen API (Sodium Salt) Company, Product Type & Application
- 3.7 Global Loxoprofen API (Sodium Salt) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Loxoprofen API (Sodium Salt) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Loxoprofen API (Sodium Salt) Players Market Share by Revenue in 2025
- 3.8.3 2025 Loxoprofen API (Sodium Salt) Tier 1, Tier 2, and Tier 3
4 Loxoprofen API (Sodium Salt) Regional Status and Outlook
- 4.1 Global Loxoprofen API (Sodium Salt) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Loxoprofen API (Sodium Salt) Historic Market Size by Region
- 4.2.1 Global Loxoprofen API (Sodium Salt) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Loxoprofen API (Sodium Salt) Sales in Value by Region (2021-2026)
- 4.2.3 Global Loxoprofen API (Sodium Salt) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Loxoprofen API (Sodium Salt) Forecasted Market Size by Region
- 4.3.1 Global Loxoprofen API (Sodium Salt) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Loxoprofen API (Sodium Salt) Sales in Value by Region (2027-2032)
- 4.3.3 Global Loxoprofen API (Sodium Salt) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Loxoprofen API (Sodium Salt) by Application
- 5.1 Loxoprofen API (Sodium Salt) Market by Application
- 5.1.1 Oral Dosage
- 5.1.2 External Preparation
- 5.2 Global Loxoprofen API (Sodium Salt) Market Size by Application
- 5.2.1 Global Loxoprofen API (Sodium Salt) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Loxoprofen API (Sodium Salt) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Loxoprofen API (Sodium Salt) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Loxoprofen API (Sodium Salt) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Loxoprofen API (Sodium Salt) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Loxoprofen API (Sodium Salt) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Loxoprofen API (Sodium Salt) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Loxoprofen API (Sodium Salt) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Anlon Healthcare
- 6.1.1 Anlon Healthcare Company Information
- 6.1.2 Anlon Healthcare Business Overview
- 6.1.3 Anlon Healthcare Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Anlon Healthcare Loxoprofen API (Sodium Salt) Product Portfolio
- 6.1.5 Anlon Healthcare Recent Developments
- 6.2 Daiichi Sankyo
- 6.2.1 Daiichi Sankyo Company Information
- 6.2.2 Daiichi Sankyo Business Overview
- 6.2.3 Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Daiichi Sankyo Loxoprofen API (Sodium Salt) Product Portfolio
- 6.2.5 Daiichi Sankyo Recent Developments
- 6.3 Metrochem
- 6.3.1 Metrochem Company Information
- 6.3.2 Metrochem Business Overview
- 6.3.3 Metrochem Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Metrochem Loxoprofen API (Sodium Salt) Product Portfolio
- 6.3.5 Metrochem Recent Developments
- 6.4 Shinpoong Pharm
- 6.4.1 Shinpoong Pharm Company Information
- 6.4.2 Shinpoong Pharm Business Overview
- 6.4.3 Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Shinpoong Pharm Loxoprofen API (Sodium Salt) Product Portfolio
- 6.4.5 Shinpoong Pharm Recent Developments
- 6.5 Dongyue Pharma
- 6.5.1 Dongyue Pharma Company Information
- 6.5.2 Dongyue Pharma Business Overview
- 6.5.3 Dongyue Pharma Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Dongyue Pharma Loxoprofen API (Sodium Salt) Product Portfolio
- 6.5.5 Dongyue Pharma Recent Developments
- 6.6 Hunan Jiudian Hongyang
- 6.6.1 Hunan Jiudian Hongyang Company Information
- 6.6.2 Hunan Jiudian Hongyang Business Overview
- 6.6.3 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product Portfolio
- 6.6.5 Hunan Jiudian Hongyang Recent Developments
- 6.7 Luoxin Pharmaceutical
- 6.7.1 Luoxin Pharmaceutical Company Information
- 6.7.2 Luoxin Pharmaceutical Business Overview
- 6.7.3 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
- 6.7.5 Luoxin Pharmaceutical Recent Developments
- 6.8 Apeloa Pharmaceutical
- 6.8.1 Apeloa Pharmaceutical Company Information
- 6.8.2 Apeloa Pharmaceutical Business Overview
- 6.8.3 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
- 6.8.5 Apeloa Pharmaceutical Recent Developments
- 6.9 Zhejiang Starry Pharmaceutical
- 6.9.1 Zhejiang Starry Pharmaceutical Company Information
- 6.9.2 Zhejiang Starry Pharmaceutical Business Overview
- 6.9.3 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
- 6.9.5 Zhejiang Starry Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Loxoprofen API (Sodium Salt) Sales by Country
- 7.1.1 North America Loxoprofen API (Sodium Salt) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Loxoprofen API (Sodium Salt) Sales by Country (2021-2026)
- 7.1.3 North America Loxoprofen API (Sodium Salt) Sales Forecast by Country (2027-2032)
- 7.2 North America Loxoprofen API (Sodium Salt) Market Size by Country
- 7.2.1 North America Loxoprofen API (Sodium Salt) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Loxoprofen API (Sodium Salt) Market Size by Country (2021-2026)
- 7.2.3 North America Loxoprofen API (Sodium Salt) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Loxoprofen API (Sodium Salt) Sales by Country
- 8.1.1 Europe Loxoprofen API (Sodium Salt) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Loxoprofen API (Sodium Salt) Sales by Country (2021-2026)
- 8.1.3 Europe Loxoprofen API (Sodium Salt) Sales Forecast by Country (2027-2032)
- 8.2 Europe Loxoprofen API (Sodium Salt) Market Size by Country
- 8.2.1 Europe Loxoprofen API (Sodium Salt) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Loxoprofen API (Sodium Salt) Market Size by Country (2021-2026)
- 8.2.3 Europe Loxoprofen API (Sodium Salt) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Loxoprofen API (Sodium Salt) Sales by Country
- 9.1.1 Asia-Pacific Loxoprofen API (Sodium Salt) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Loxoprofen API (Sodium Salt) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Loxoprofen API (Sodium Salt) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Loxoprofen API (Sodium Salt) Market Size by Country
- 9.2.1 Asia-Pacific Loxoprofen API (Sodium Salt) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Loxoprofen API (Sodium Salt) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Loxoprofen API (Sodium Salt) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Loxoprofen API (Sodium Salt) Sales by Country
- 10.1.1 South America Loxoprofen API (Sodium Salt) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Loxoprofen API (Sodium Salt) Sales by Country (2021-2026)
- 10.1.3 South America Loxoprofen API (Sodium Salt) Sales Forecast by Country (2027-2032)
- 10.2 South America Loxoprofen API (Sodium Salt) Market Size by Country
- 10.2.1 South America Loxoprofen API (Sodium Salt) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Loxoprofen API (Sodium Salt) Market Size by Country (2021-2026)
- 10.2.3 South America Loxoprofen API (Sodium Salt) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Loxoprofen API (Sodium Salt) Sales by Country
- 11.1.1 Middle East and Africa Loxoprofen API (Sodium Salt) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Loxoprofen API (Sodium Salt) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Loxoprofen API (Sodium Salt) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Loxoprofen API (Sodium Salt) Market Size by Country
- 11.2.1 Middle East and Africa Loxoprofen API (Sodium Salt) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Loxoprofen API (Sodium Salt) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Loxoprofen API (Sodium Salt) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Loxoprofen API (Sodium Salt) Value Chain Analysis
- 12.1.1 Loxoprofen API (Sodium Salt) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Loxoprofen API (Sodium Salt) Production Mode & Process
- 12.2 Loxoprofen API (Sodium Salt) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Loxoprofen API (Sodium Salt) Distributors
- 12.2.3 Loxoprofen API (Sodium Salt) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst